Nasal COVID-19 Vaccine Utilizing WashU Technology Set to Begin Clinical Trials in the U.S.
A nasal vaccine for COVID-19, utilizing groundbreaking technology developed at Washington University in St. Louis, is on the brink of entering a Phase 1 clinical...








